
Varixio® selected for funding
Our Varixio® project has been selected for funding by the EU’s Horizon 2020 research and innovation programme. The project is
Our Varixio® project has been selected for funding by the EU’s Horizon 2020 research and innovation programme. The project is
Our experience with Varixio® presented at the Proof of Concept Event organized by Eurecat. The presentation was addressed to young
La Vanguardia has featured our partnership with Eurecat Eurocat is a Technology Centre (a member of Tecnio) that will help
An update of the VB Foamer Device development led by Enric Roche and VB Devices was presented at The World Congress of Phlebology which has been held in Melbourne from February 4th-8th 2018.
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 887677
Necessary cookies only include cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function.
Analytical cookiesFederico Grego has more than 20 years of experience in the pharmaceutical industry (LETI Pharma), in senior management positions, coupled with 4 years of experience in investment banking (HSBC). He also has extensive experience in the biomedical entrepreneurship sector helping to promote various projects, including Cytovation AS, Allero Therapeutics, and Nexkin Medical, among others. He is an economist (Tufts University), MBA (IESE) and AMP Certificate (Harvard).